Skip to content

Ayurveda treatment protocol along with lifestyle modification in the management of Artavadushti W.S.R. to non-obese PCOS

Efficacy of Nitya Virechana with Naracha Choorna,Shatapushpa Taila Matrabasti and Shatapushpadi Yoga orally along with Lifestyle modification in the management of Artavadushti W.S.R. to non- obese Polycystic ovarian syndrome: a randomized placebo-controlled clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111374
Enrollment
30
Registered
2026-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N830- Follicular cyst of ovary

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Both married /unmarried patients in the age group of 18-40 years. 2. Diagnosed cases as per Rotterdam criteria (2018)-ASRM (American Society for Reproductive Medicine) criteria for PCOS. 3. Patient willing to give written informed consent by themselves. 4. BMI less than or equal to 25 kg/m2 5. Patients eligible for Basti Karma.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from chronic pelvic diseases like (Endometriosis, PID, Uterine Fibroid, Menorrhagia, etc.) 2. Organic lesions of reproductive tract like Tuberculosis, Carcinoma and congenital deformities and Sexually Transmitted Diseases. 3. Patients with history of cardiac diseases, uncontrolled hypertension (Systolic BP above 160 & Diastolic above 100mmhg), uncontrolled Diabetes Mellitus (FBS- above the range of 160 mg/dl). 4. Patients having Hypothyroidism

Design outcomes

Primary

MeasureTime frame
Reduction in ovarian volume in cm on USG and ovulation induction assessed by follicular study on USG.Timepoint: It is expected that trial drugs will help in the reduction of ovarian volume and induce ovulation after 8 weeks of treatment.

Secondary

MeasureTime frame
Regulation of menstrual pattern and reduction in hyperandrogenism (clinical/biochemical), improvement of the general health and QOL.Timepoint: 60 days

Countries

India

Contacts

Public ContactDr Shilpa B Donga

Institute of Teaching and Research in Ayurveda INI Jamnagar

drshilpadonga@yahoo.com9825646796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026